Tower Research Capital (TRC)’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $42.7K | Buy |
|
|||||
|
2025
Q2 | $26.2K | Buy |
|
|||||
|
2025
Q1 | $10.8K | Sell |
|
|||||
|
2024
Q4 | $26.7K | Sell |
|
|||||
|
2024
Q3 | $102K | Buy |
|
|||||
|
2024
Q2 | $41K | Buy |
|
|||||
|
2024
Q1 | $6.16K | Sell |
|
|||||
|
2023
Q4 | $87.2K | Buy |
|
|||||
|
2023
Q3 | $15.8K | Buy |
|
|||||
|
2023
Q2 | $8.99K | Sell |
|
|||||
|
2023
Q1 | $19K | Buy |
|
|||||
|
2022
Q4 | $6K | Sell |
|
|||||
|
2022
Q3 | $40K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $23K | Buy |
|
|||||
|
2021
Q4 | $42K | Buy |
|